EIF3E and non-small cell lung carcinoma: Frequent loss of heterozygosity (LOH) of Int6 in both breast and non-small cell lung carcinomas (NSCLC) [21,22] and decreased expression of Int6 through hypermethylation of the promoter and first exon in NSCLC [23] suggest that normal Int6 function might be sensitive to the level of expression.